Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Novaquest Capital Management

Investor type Venture Capital


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 14
Average round size
The average size of a deal this fund participated in
Portfolio companies 14
Rounds per year 1.17
Lead investments 3
Exits 6
Key employees 10
Stages of investment

Areas of investment

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Medical
  • Clinical Trials

Novaquest Capital Management appeared to be the VC, which was created in 2010. The company was established in North America in United States. The main department of described VC is located in the Raleigh.

The higher amount of exits for fund were in 2014. The important activity for fund was in 2018. Despite it in 2019 the fund had an activity. The fund is constantly included in less than 2 deals per year. The usual things for fund are deals in the range of 50 - 100 millions dollars. The typical startup value when the investment from Novaquest Capital Management is more than 1 billion dollars. This Novaquest Capital Management works on 11 percentage points more the average amount of lead investments comparing to the other organizations. The real fund results show that this VC is 40 percentage points more often commits exit comparing to other companies.

The fund has exact preference in some founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Roivant Sciences, PreCision Dermatology, Clinical Ink. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular fund investment industries, there are Medical, Health Care.

We also calculated 10 valuable employees in our database.

The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the Novaquest Capital Management, startups are often financed by FCA Venture Partners, Viking Global Investors, SoftBank Investment Advisers. The meaningful sponsors for the fund in investment in the same round are Viking Global Investors, TT Capital Partners, SoftBank Investment Advisers. In the next rounds fund is usually obtained by Silicon Valley Bank, RTI International, CIBC.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Novaquest Capital Management:
Typical Co-investors
Novaquest Capital Management is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Novaquest Capital Management:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Alumot VC Israel, Tel Aviv, Tel Aviv District
Anhui Zhongding Sealing Parts Anhui, China, Ningguo
Anzu Partners District of Columbia, United States, Washington
Aurec Group Israel, Ramat Gan, Tel Aviv
BIXINK Therapeutics -
CYTS California, San Francisco, United States
Dropbox California, San Francisco, United States
GENTOSHA MediaConsulting Japan, Tokyo
o3 Capital India, Maharashtra, Mumbai
Ontario Media Development Corporation Canada, Ontario, Toronto
Pathfinder California, San Francisco, United States
Pengle Network Technology Beijing, Beijing, China
RMKB Ventures -
Shanxi Heling Touzi guanli Co., Ltd. China, Shaanxi, Xian Shi
SIIF Chiba, Japan, Minato
SPD International Australia, Melbourne, Victoria
Squadron Medical Finance Solutions -
Start Capital England, London, United Kingdom
Tethys Investment Management Cambridge, Massachusetts, United States
TinkBig Venture Kuala Lumpur, Malaysia

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Hansa Biopharma

Health Care
$70M18 Jul 2022 Lund, Skane Lan, Sweden

Applied LifeSciences & Systems

Innovation Management
Life Science
$35M25 May 2022 North Carolina, United States

Dermavant Sciences

Health Care
$160M07 Jun 2021 Basel, Basel-Stadt, Switzerland


Health Care
$35M03 May 2021 Durham, North Carolina, United States


Clinical Trials
$20M19 Oct 2020 North District

Arvelle Therapeutics

$42M27 May 2020 Basel, Basel-City, Switzerland


Health Care
24 Dec 2019 Saint Petersburg, Florida, United States


$50M18 Jun 2019 Bridgewater, New Jersey, United States

Roivant Sciences

Health Care
Product Research
$200M13 Nov 2018 New York, New York, United States


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Novaquest Capital Management?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: